Long-Term Outcomes After Ustekinumab Dose Intensification for Inflammatory Bowel Diseases. Dalal RS, Pruce JC, Allegretti JR. Inflamm Bowel Dis 2023;29:830-833.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dalal RS, Pruce JC, Allegretti JR. Long-Term Outcomes After Ustekinumab Dose Intensification for Inflammatory Bowel Diseases. Inflamm Bowel Dis 2023;29:830-833.
PMID: 35907202